ITGB3BP
Basic information
Region (hg38): 1:63440769-63593721
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGB3BP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 4 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 0 | |||||
Total | 0 | 0 | 4 | 0 | 0 |
Variants in ITGB3BP
This is a list of pathogenic ClinVar variants found in the ITGB3BP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-63446850-C-G | not specified | Uncertain significance (Jan 23, 2023) | ||
1-63453963-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
1-63453969-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
1-63454426-A-C | not specified | Uncertain significance (Feb 27, 2024) | ||
1-63454895-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
1-63454964-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
1-63454968-T-C | not specified | Likely benign (Aug 15, 2023) | ||
1-63525594-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
1-63525597-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
1-63525624-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
1-63525747-C-A | not specified | Uncertain significance (Jun 03, 2022) | ||
1-63531841-A-G | not specified | Uncertain significance (Nov 21, 2022) | ||
1-63532716-T-G | not specified | Uncertain significance (Jun 29, 2023) | ||
1-63532754-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
1-63533523-A-G | Benign (Feb 25, 2018) | |||
1-63534124-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
1-63534182-G-A | not specified | Likely benign (Mar 05, 2024) | ||
1-63545939-AG-A | Postaxial polydactyly | Uncertain significance (-) | ||
1-63545947-T-G | not specified | Uncertain significance (Dec 28, 2022) | ||
1-63551817-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
1-63557137-A-C | not specified | Uncertain significance (Mar 22, 2023) | ||
1-63561706-CAG-C | Postaxial polydactyly | Uncertain significance (-) | ||
1-63561723-A-G | not specified | Uncertain significance (Nov 09, 2023) | ||
1-63561775-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
1-63561783-C-G | not specified | Uncertain significance (Apr 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITGB3BP | protein_coding | protein_coding | ENST00000371092 | 9 | 152952 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.96e-7 | 0.324 | 125734 | 0 | 12 | 125746 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.494 | 78 | 91.3 | 0.854 | 0.00000422 | 1409 |
Missense in Polyphen | 12 | 17.918 | 0.66973 | 303 | ||
Synonymous | -0.0445 | 30 | 29.7 | 1.01 | 0.00000138 | 363 |
Loss of Function | 0.483 | 11 | 12.9 | 0.855 | 6.02e-7 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000886 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000362 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription coregulator that can have both coactivator and corepressor functions. Isoform 1, but not other isoforms, is involved in the coactivation of nuclear receptors for retinoid X (RXRs) and thyroid hormone (TRs) in a ligand-dependent fashion. In contrast, it does not coactivate nuclear receptors for retinoic acid, vitamin D, progesterone receptor, nor glucocorticoid. Acts as a coactivator for estrogen receptor alpha. Acts as a transcriptional corepressor via its interaction with the NFKB1 NF- kappa-B subunit, possibly by interfering with the transactivation domain of NFKB1. Induces apoptosis in breast cancer cells, but not in other cancer cells, via a caspase-2 mediated pathway that involves mitochondrial membrane permeabilization but does not require other caspases. May also act as an inhibitor of cyclin A- associated kinase. Also acts a component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex. {ECO:0000269|PubMed:11713274, ECO:0000269|PubMed:12244126, ECO:0000269|PubMed:15082778, ECO:0000269|PubMed:15254226, ECO:0000269|PubMed:16622420}.;
- Pathway
- Signal Transduction;Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal;Amplification of signal from the kinetochores;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RHO GTPases Activate Formins;Nucleosome assembly;RHO GTPase Effectors;Signaling by Rho GTPases;Chromosome Maintenance;NRIF signals cell death from the nucleus;Deposition of new CENPA-containing nucleosomes at the centromere;Death Receptor Signalling;p75 NTR receptor-mediated signalling;Mitotic Prometaphase;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;Cell Cycle, Mitotic;Cell death signalling via NRAGE, NRIF and NADE
(Consensus)
Recessive Scores
- pRec
- 0.0856
Intolerance Scores
- loftool
- 0.753
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.68
Haploinsufficiency Scores
- pHI
- 0.0902
- hipred
- N
- hipred_score
- 0.412
- ghis
- 0.658
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.229
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Itgb3bp
- Phenotype
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;apoptotic process;cell cycle;cell adhesion;signal transduction;CENP-A containing nucleosome assembly;positive regulation of apoptotic process;cell division
- Cellular component
- condensed chromosome kinetochore;nucleus;nucleoplasm;cytoplasm;cytosol;membrane
- Molecular function
- protein binding;protein C-terminus binding